Sosei Heptares’ COVID-19 Program Identifies Potent Broad Spectrum Anti-Viral Small Molecules for Further Development

TOKYO and CAMBRIDGE, England, Nov. 20, 2020 /PRNewswire/ — SoseiĀ Group Corporation (“the Company”) (TSE: 4565) announces a progress update for its R&D program focused on the design and developmeā€¦ [read more]

Leave a Comment